Drug Detail:Dipyridamole (Dipyridamole (oral/injection) [ dye-pir-id-a-mole ])
Drug Class: Cardiac stressing agents Platelet aggregation inhibitors
Dipyridamole Levels and Effects while Breastfeeding
Summary of Use during Lactation
No published information is available on the use of dipyridamole during breastfeeding, although labeling states that the drug is excreted into human milk. Until more data become available, dipyridamole should be used with caution during breastfeeding, especially while nursing a newborn or preterm infant. If it is used by a nursing mother, monitor the infant for bruising and bleeding.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Aspirin
Substance Identification
Substance Name
Dipyridamole
CAS Registry Number
58-32-8
Drug Class
-
Breastfeeding
-
Lactation
-
Phosphodiesterase Inhibitors
-
Vasodilator Agents
-
Platelet Aggregation Inhibitors
-
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- Drug Levels and Effects
- Substance Identification